You are here: Home
 
Banner
Novartis receives EU approval for Farydak®, the first in its class of anticancer agents approved for patients with multiple myeloma

Novartis receives EU approval for Farydak®, the first in its class of anticancer agents approved for patients with multiple myeloma

Farydak (panobinostat) combination is approved in the EU for patients with multiple myeloma who received >=2 prior regimens including bortezomib and IMiD.

Shire to Attain Enhanced CINRYZE® Manufacturing Flexibility and Capacity

Shire to Attain Enhanced CINRYZE® Manufacturing Flexibility and Capacity

Shire to Attain Enhanced CINRYZE® Manufacturing Flexibility and Capacity

Novo Nordisk plans 2 billion US dollar investment in new production facilities in Clayton, North Carolina and Måløv, Denmark

Novo Nordisk plans 2 billion US dollar investment in new production facilities in Clayton, North Carolina and Måløv, Denmark

Novo Nordisk plans to invest an estimated 2 billion US dollars over the next five years in new production facilities in Clayton, North Carolina, US and Måløv, ...

Banner

Knowledge Bank

Edit

Amount of short articles:

Amount of articles links:

You can order sections with dragging on list bellow:

  • Knowledge Bank
Save
Cancel
Reset

News

Mersana Therapeutics and Takeda Expand Partnership to Advance Development of Fleximer® Antibody-Drug Conjugates and

• Takeda obtains rights to Mersana’s XMT-1522 outside U.S. and Canada • Takeda to create additional Fleximer ADCs; Mersana to have a co-development option • Mersana to receive $40 million upfront, $20

Monday, 8 February 2016 Comments

Press Releases

FDA Psychopharmacologic Drug Advisory Committee Supports the Effectiveness of Brintellix® (vortioxetine) in Treating Certain Aspects of Cognitive Dysfunction in Major Depressive Disorder

•    The panel voted 8-2 that substantial evidence has been presented to support a claim of effectiveness for Brintellix for treating certain aspects of cognitive dysfunction in MDD•    The panel

Monday, 8 February 2016 Comments

Research Insight

SINE™ Technology

A human cell is divided into various compartments, including the nucleus and the cytoplasm.  The nucleus contains a cell’s genetic material, or DNA, and is the compartment where gene expression

Thursday, 28 January 2016 Comments

Techno Trends

Novartis Access

The menace of noncommunicable diseases (NCDs) like cardiovascular diseases, diabetes and cancer in the developing world is increasing. These conditions disproportionally affect poverty-stricken areas. Already today 28 million people die

Friday, 29 January 2016 Comments

Industry Reports

INNATE PHARMA IN-LICENSES OREGA BIOTECH'S FIRST-IN-CLASS ANTI-CD39 CHECKPOINT INHIBITOR

This program, currently in preclinical development, aims at developing an anti-CD39 mAb; Targeting the adenosine immunosuppressive pathway has potential to promote anti-tumor immune responses across a wide range of tumors; Anti-CD39 broadens In

Thursday, 28 January 2016 Comments

Articles

Gastroesophageal Reflux Disease (GERD or

Gastroesophageal Reflux Disease is a condition resulting from stomach acid moving backward from the stomach into the esophagus (the tube that connects the mouth to the stomach). The acid causes

Tuesday, 9 February 2016 Comments

Banner